 |
Dr. Dennis Giesing, Senior Vice President,
Aventis Phamaceuticals
The pharmaceutical industry is developing
groundbreaking drugs that promise to substantially improve patient wellness
and quality of life. There are substantial challenges in managing the complexity,
cost and cycle time for new drug programs and result in major obstacles
to the industry as evidenced by recent declines in pharmaceutical productivity.
The presentation outlined elements responsible for the current issues which
global cross-functional project teams and organizations must address. Dr.
Giesing shared current environmental and operational challenges such as
increased disease and technology complexity, escalating product price and
lifecycle pressures, R&D pipeline attrition, and effective project
risk and cost management. Dr. Giesing also discussed the best practices
used to address these challenges such as multi-component optimization,
global project plan design and optimization, continuous process improvement,
and leading edge approaches to new operations support systems.
Dr. Dennis Giesing is Sr. VP, Lead Optimization
at Aventis Pharmaceuticals Inc and oversees translational research programs
directed toward converting discovery stage candidates into late stage clinical
products. His organization has locations in Germany, France, Japan
and Bridgewater, NJ.
Dennis' view
graphs can be downloaded. |
